FDA approves new migraine treatment SYMBRAVO
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.28 billion biopharmaceutical company with impressive 51% revenue ...
Southwest Airlines expects slower pace of cost increases, but inflation persists
Southwest (LUV) said that it still faces pressure from inflation but that its cost per available seat mile excluding fuel and special items (CASM-X) will cool from a rate of 11.1% in the fourth ...
TD Cowen raises ADP stock price target to $294, maintains Hold rating
TD Cowen adjusted its price target for ADP (NASDAQ: ADP) shares, increasing it marginally from $290.00 to $294.00, while maintaining a Hold rating on the stock. The price target revision reflects the ...
TD Cowen Remains a Buy on MAG Silver (MAG)
In a report released today, Craig Hutchison from TD Cowen maintained a Buy rating on MAG Silver (MAG – Research Report), with a price target of ...
How Washington may respond to a Chinese startup disrupting America's AI ambitions
Paul Gallant, Managing Director at TD Cowen Washington Research Group, discusses the recent release of Chinese AI Assistant ...
TD Cowen Remains a Hold on Liberty Oilfield Services (LBRT)
In a report released today, Marc Bianchi from TD Cowen maintained a Hold rating on Liberty Oilfield Services (LBRT – Research Report), with a ...
Thursday’s analyst upgrades and downgrades
Maintaining his 2025 EPS forecast of $4.99, which represents 17-per-cent growth, the analyst “slightly” moderated his 2026 ...